Page last updated: 2024-12-08

1-deaza-fad

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

**1-Deaza-FAD** is a modified form of the coenzyme flavin adenine dinucleotide (FAD). It differs from FAD in that the nitrogen atom at position 1 of the isoalloxazine ring is replaced with a carbon atom.

**Importance for Research:**

**1. Studies on Flavin-Dependent Enzymes:**

* 1-Deaza-FAD is a potent inhibitor of many flavin-dependent enzymes. It acts by binding to the active site of the enzyme and blocking the normal function of FAD.
* This property makes 1-deaza-FAD a valuable tool for studying the mechanism of flavin-dependent enzymes.
* By inhibiting the enzyme, researchers can identify the role of FAD in the catalytic cycle and gain insights into the enzyme's structure and function.

**2. Elucidating the Role of FAD in Biological Processes:**

* 1-Deaza-FAD can be used as a probe to investigate the role of FAD in various biological processes.
* For example, researchers have used 1-deaza-FAD to study the role of FAD in electron transfer reactions, redox signaling, and DNA repair.

**3. Development of Therapeutics:**

* The inhibitory properties of 1-deaza-FAD have led to its potential use in developing new therapeutic agents.
* For instance, 1-deaza-FAD derivatives have been investigated as potential inhibitors of certain cancer cells.

**Specific Applications:**

* **Enzyme kinetics:** 1-Deaza-FAD is used to determine kinetic parameters of flavin-dependent enzymes.
* **Structural studies:** It can be used to crystallize flavin-dependent enzymes in complex with the inhibitor, providing insights into the active site structure.
* **Drug discovery:** 1-Deaza-FAD serves as a lead compound for the development of novel drugs that target flavin-dependent enzymes.

**Overall, 1-deaza-FAD is a versatile tool in research, providing insights into the function of flavin-dependent enzymes, facilitating the development of therapeutics, and advancing our understanding of fundamental biological processes.**

1-deaza-FAD: RN & N1 from 9th CI Form Index; cpd not in Chemline 7/14/83 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID194041
MeSH IDM0080640

Synonyms (7)

Synonym
deazafad
57818-88-9
[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxopyrimido[4,5-b]quinolin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate
1-deaza-fad
adenosine 5'-(trihydrogen diphosphate), 5-5'-ester with 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxopyrimido(4,5-b)quinolin-10(2h)-yl)-d-ribitol
5-deazariboflavin-5'-diphosphate
AKOS040749896
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (37.50)18.7374
1990's3 (18.75)18.2507
2000's7 (43.75)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.67 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]